Cargando…

Gender-based differences in brain and plasma pharmacokinetics of letrozole in sprague-dawley rats: Application of physiologically-based pharmacokinetic modeling to gain quantitative insights

Based on the discovery that the estrogen synthase aromatase (CYP19A1) is abundantly expressed in high- grade gliomas, the aromatase inhibitor, letrozole is being investigated in pre-clinical models as a novel agent against this malignancy. Here, we investigated the systemic and brain pharmacokinetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Priyanka, Gudelsky, Gary, Desai, Pankaj B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018653/
https://www.ncbi.nlm.nih.gov/pubmed/33798227
http://dx.doi.org/10.1371/journal.pone.0248579